Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DTC Use By Pharma May Increase Due To Sales Force Cuts, Study Suggests

Executive Summary

Sales force reductions may force pharmaceutical companies to increase use of direct-to-consumer advertising to drive revenues, according to a report by the market research group Guideline

You may also be interested in...

Pfizer’s Manufacturing Cost-Cutting May Leave Little Capacity For Growth

Following its restructuring, Pfizer's in-house manufacturing capacity will support approximately $48 billion in sales

DTC Guideline Implementation: Does “Ask Your Doctor” Spark A Dialogue?

As industry continues to implement PhRMA's guidelines on direct-to-consumer ads, debate has arisen as to how companies can effectively enact the principle that advertising should encourage a conversation between patient and physician

Brand DTC Better Than Disease Awareness Ads At Driving Patients To Doctor

Direct-to-consumer branded advertisements are more effective in motivating patients to visit their doctors than disease awareness ads, Pfizer President-U.S. Pharmaceuticals Patrick Kelly said Nov. 1

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts